A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells

Recently, interactions between thrombopoietin (TPO) and its receptor, the myeloproliferative leukemia (MPL) virus oncogene, have been shown to play a role in the development and progression of myeloproliferative neoplasms including myelofibrosis (MF). These observations have led to the development o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood
Päätekijät: Wang, Xiaoli, Haylock, David, Hu, Cing Siang, Kowalczyk, Wioleta, Jiang, Tianbo, Qiu, Jiajing, Mosoyan, Goar, He, Wu, Marshall, Netonia, Mascarenhas, John, Tarasova, Anna, Brody, Joshua, Winkler, David, Hoffman, Ronald
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2016
Aiheet:
Myeloid Neoplasia
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4929928/
https://ncbi.nlm.nih.gov/pubmed/27114459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-10-674465
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia